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and Roberto Ratiglia
PURPOSE. To evaluate morphologic changes in meibomian
glands (MGs) and the status of periglandular inflammation in
patients with primary and secondary Sjo¨gren’s Syndrome (SS)
using in vivo confocal laser microscopy (LSCM).
METHODS. Twenty patients with primary SS (SSI), 25 with second-
ary SS (SSII), 20 with MG dysfunction (MGD), and 25 age- and
gender-matched control subjects were enrolled consecutively.
Each participant completed anOcular Surface Disease Index ques-
tionnaire and underwent a full eye examination, including tear
film break-up time (BUT), fluorescein and lissamine green stain-
ing, Schirmer test, and an LSCM examination of the MGs, the last
to determine acinar unit density and diameter, glandular orifice
diameters, meibum secretion reflectivity, inhomogeneous appear-
ance of glandular interstice, and acinar wall.
RESULTS. All parameters indicated statistically significant differ-
ences among groups (P  0.001, Kruskal-Wallis test). LSCM
demonstrated no differences between SSI and SSII (Mann–
Whitney U test). Compared with control subjects, SS subjects’
MGs showed more periglandular inflammation and higher se-
cretion reflectivity (P  0.001, Mann–Whitney U test). Com-
pared with MGD patients, SS patients’ MGs had higher acinar
density, smaller diameters, greater density of periglandular
inflammatory cells, and lower secretion reflectivity (P 0.001,
Mann–Whitney U test). In SS patients, the two measured con-
focal signs of inflammation were significantly interrelated and
correlated with corneal fluorescein staining (P  0.01, Spear-
man correlation coefficient). Acinar density and diameters
were strongly correlated among themselves (P  0.001) and
with BUT (P  0.05).
CONCLUSIONS. LSCM is capable of effectively revealing morpho-
logic and inflammatory changes in MGs and showed discern-
ible patterns of MG abnormalities in SS and MGD not easily
distinguishable by the usual clinical exams. (Invest Ophthal-
mol Vis Sci. 2011;52:933–939) DOI:10.1167/iovs.10-5995
Sjo¨gren’s Syndrome (SS), a relatively common chronic auto-immune disorder affecting 1%–2% of the population, is
characterized by dysfunction and destruction of exocrine
glands— mainly salivary and lacrimal glands. SS can be found
alone—primary SS (SSI)—or accompanied by almost any other
autoimmune disease–secondary SS (SSII), wherein a broad
spectrum of clinical symptoms that extend from the exocrine
glands (organ-specific exocrinopathy) to extraglandular mani-
festations (systemic disease) can be observed.1
Epithelial cells are thought to play important pathogenetic
roles, as suggested by the occurrence of infiltrating lesions in
various epithelial tissues (described as autoimmune epithelii-
tis) as well as increased epithelial expression of several inflam-
matory proteins in the lesions of patients. Epithelial cells in SS
are activated and are capable of acting as antigen-presenting
cells.2–4
SS is classically characterized by oral (xerostomia) and oc-
ular dryness, keratoconjunctivitis sicca (KCS). For many years,
KCS associated with SS was considered to be the result of
reduced secretion of the aqueous component in tears.5 Today,
other pathogenetic elements, such as inflammation, changes in
tear osmolarity, and alterations in corneal sensitivity and inner-
vation, are considered to be fundamental. These elements
interact in a complex (although, as yet, not completely de-
coded) manner within the ocular surface morpho-functional
unit that comprises the tear film, cornea, limbus, conjunctiva,
mucocutaneous junction, and lacrimal (principal and acces-
sory) and meibomian glands (MGs).5,6
MGs are holocrine, lipid-excreting glands embedded in the
tarsal plate of the upper and lower lids. Each MG comprises
multiple acini that are connected by a long common central
duct running throughout the entire length of the gland. MG
dysfunction (MGD) is a term primarily used to describe ob-
structive MG disease. MGD, a major cause of evaporative dry
eye, causes alteration and reduction of lipid secretions, leading
to increased tear evaporation, decreased tear stability, loss of
lubrication, and damage to the ocular surface epithelia.6–8
Previous studies have also shown abnormal evaporation rates
and clinically significant destruction of MGs in patients with
“hyposecretive” KCS associated with SS.9,10
In vivo confocal laser microscopy (LSCM) is a new emerging
noninvasive technology that is useful as a supplementary diag-
nostic tool for in vivo assessment of the histopathology of
many ocular surface disorders,11 including in vivo examination
of MGs. 12–14 In this study we evaluated the morphologic
changes of MGs and the status of periglandular inflammation in
patients with SSI and SSII using LSCM and investigated the
correlation between clinical and confocal findings.
METHODS
Patients
We consecutively enrolled 20 patients with SSI (20 women; mean age,
53.3  20 years; range, 35–72 years), 25 patients with SSII (23 women
and two men; mean age, 53  11 years; range, 42–65 years), 20
patients with MGD (mean age, 52 10 years; range, 40–60 years), and
25 healthy control subjects (18 women and 7 men; mean age, 50  15
years; range, 20–80 years).
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Patients with SSI and SSII were recruited at the Referral Centre for
Systemic Autoimmune Diseases of Fondazione Ca` Granda IRCCS, Os-
pedale Maggiore Policlinico. The diagnosis was made according to
American-European Consensus Group criteria.15 MGD and control pa-
tients were recruited at the General Clinic of Ophthalmology of Fonda-
zione Ca` Granda IRCCS, Ospedale Maggiore Policlinico. The diagnosis
of MGD was made according to criteria reported by Matsumoto et al.12
Exclusion criteria for all groups included lymphoma, AIDS, diabetes
mellitus, contact lens wear, history of eye surgery, and systemic or
topical therapy with FAN, steroids, or drugs with known corneal
toxicity.
Written informed consent was obtained from all subjects before
examination. This study adhered to the tenets of the Declaration of
Helsinki.
Clinical Evaluation
An accurate medical history was recorded for all study participants. All
patients completed a questionnaire for standardized evaluation of dry
eye–related symptoms: the Ocular Surface Disease Index. All patients
underwent a thorough ophthalmic evaluation, including biomicro-
scopic examination of the ocular adnexa and anterior segment.
FIGURE 1. (A) Superficial and (B)
basal epithelium of the eyelid mar-
gin.
FIGURE 2. Secretion reflectivity in
MGs. Grading 1–4: (A) grade 1, black
color of secretion; (B) grade 2, dark
gray color of secretion; (C) grade 3,
light gray color of secretion; (D)
grade 4, white color of secretion.
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To evaluate MGs, transillumination observation (meibography) of
the lower eyelid was performed using a fiber-optic device. The degree
of MG dropout was scored, as described previously8,10: grade 0  no
gland dropout; grade 1  gland dropout in less than half of the inferior
tarsus; and grade 2  gland dropout in more than half of the inferior
tarsus.
Tear film break-up time (BUT), corneal staining with fluorescein,
and bulbar conjunctival staining with lissamine green were also
performed. Ocular surface staining was scored according to the
Collaborative Longitudinal Evaluation of Keratoconus scheme.5
Tear secretion was evaluated by the Schirmer test using oxybu-
procaine chloridrate 0.4%. Assessment of obstruction in MG orifices
was conducted by applying digital pressure on the upper tarsus,
after which the degree of ease in expressing MG secretion
(meibum) was evaluated semiquantitatively: grade 0  clear
meibum easily expressed; grade 1  cloudy meibum expressed with
mild pressure; grade 2  cloudy meibum expressed with more than
moderate pressure; and grade 3  meibum not expressed even with
firm pressure.8,10
Both eyes of all subjects were examined. For statistical analysis, the
eye with the highest fluorescein staining score was selected. In the
case of equal scores for the two eyes, discriminant criteria considered
were, in order of relevance, conjunctival staining and BUT.
Confocal Microscopy
Image Acquisition. LSCM was performed on all subjects using
a new-generation confocal microscope (HRT II Corneal Rostock Mod-
ule; Heidelberg Engineering, Dossenheim, Germany), which employs a
670 nm scanning wavelength. The objective lens (Zeiss 63 immer-
sion) is covered with a polymethacrylate sterile cap (Tomo-Cap;
Heidelberg Engineering) and has a working distance of 0.0–2.0 mm.
Before each examination, a drop of oxybuprocaine chlorohydrate 0.4%
and an ophthalmic polyacrylic gel 0.2% were separately instilled into
the conjunctival fornix. After the lower eyelid was partially everted,
the center of the sterile cap was applanated onto the center of the
eyelid margin (horizontally halfway between the inner and outer can-
thi), and the instrument focus manually settled (microscope in acqui-
sition modality “Section Mode”), starting from the most superficial
down to the deepest discernible tissues having a satisfactory resolu-
tion. Ten images were taken every 10 m in depth. Additional images
were also taken mid-depth, to manually adjust the quality of the
different structures during examination. This procedure was repeated
for the nasal and temporal eyelid margins.
Two-dimensional image sizes measured 384  384 pixels, with a
400  400 m field of view. Each LSCM examination session lasted
3–5 minutes.
Image Analysis. For each variable examined, a single masked
investigator (SB) analyzed three randomized, nonoverlapping high-
quality digital images of the nasal, middle, and temporal lower
eyelid margins. We quantified the following variables: cellular den-
sity of the superficial and basal epithelia of the eyelid margin (Fig. 1;
manually marked inside the largest available region of interest and
calculated automatically) (Cell Count software; Heidelberg Engi-
neering), diameters of acinar units (manually measured along the
longest axis of the acinar unit), density of MGs (manually marked
inside each 400  400 m frame and calculated automatically using
Cell Count),12 diameter of glandular orifices (manually marked
along the longest axis of orifice), meibum secretion reflectivity
FIGURE 3. Inhomogeneous appear-
ance of interstice of acinar unit.
Grading 1–4: (A) grade 1, absence of
punctate reflecting elements: (B)
grade 2, slight presence of punctate
reflecting elements; (C) grade 3,
greater presence of punctate reflect-
ing elements; (D) grade 4, higher
presence of punctate reflecting ele-
ments.
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(Fig. 2), and inhomogeneous appearance of interstices and walls of
acinar units (Figs. 3 and 4). For the last three variables, we adopted
three grading scales (1–4) assessed by comparison with the refer-
ence images (Figs. 2–4). Values obtained by the same investigator
(SB) 1 month later and by a second independent investigator (MDC)
were used to quantify intra- and interobserver agreement, respec-
tively.
Statistical Analysis
All data are presented as mean SD. For each variable, the Kruskal-Wallis
test was applied to test the statistical differences between the four groups.
The Mann–Whitney U test was used as a post hoc test to determine the
difference between individual pairs of groups. Correlations among vari-
ables were analyzed with Spearman’s index of linear correlation.
TABLE 1. Clinical Data





SSI 26.5  12.8 1.3  0.7 3.7  1.8 4.2  3.3 2.7  0.9 1.9  0.9 1.7  0.9
SSII 18.2  6.9 1.2  0.7 5.1  2.9 2.8  1.9 1.6  0.5 3  1.9 1.7  0.9
MGD 13.3  9.8 1.6  0.5 5.4  1.7 1.2  0.9 1.2  0.9 12.3  1.9 2.5  0.6
C 4.9  3.4 0.4  0.5 9.2  3.1 n.s. n.s. 9.5  5.6 0.4  0.5
P* 0.001† 0.001‡ 0.001§ 0.001 0.001¶ 0.001# 0.001**
* P obtained by Kruskal-Wallis test; n.s., not significant.
† SSI vs. SSII: P  0.01; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD vs. C: P  0.01; SSI vs. MGD: P  0.001; SSII vs. MGD: n.s.
(Mann-Whitney U test).
‡ SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD vs. C: P  0.001; SSI vs. MGD: P  0.05; SSII vs. MGD: P  0.05
(Mann-Whitney U test).
§ SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD vs. C: P  0.001; SSI vs. MGD: P  0.01; SSII vs. MGD: n.s. (Mann-Whitney U test).
 SSI vs. SSII: n.s.; SSI vs. MGD: P  0.001; SSII vs. MGD: P  0.01 (Mann-Whitney U test).
¶ SSI vs. SSII: P  0.001; SSI vs. MGD: P  0.001; SSII vs. MGD: n.s. (Mann-Whitney U test).
# SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD vs. C: P  0.001; SSI vs. MGD: P  0.001; SSII vs. MGD: P  0.001
(Mann-Whitney U test).
** SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD vs. C: P  0.001; SSI vs. MGD: P  0.001; SSII vs. MGD: P  0.001
(Mann-Whitney U test).
FIGURE 4. Inhomogeneous appear-
ance of wall of acinar unit. Grading
1–4: (A) grade 1, absence of punc-
tate reflecting elements; (B) grade 2,
slight presence of punctate reflecting
elements; (C) grade 3, greater pres-
ence of punctate reflecting elements;
(D) grade 4, greatest presence of
punctate reflecting elements.
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The minimum criterion for tests of significance was P  0.05.
Statistical analysis was conducted using commercial software (SPSS for
Windows, v. 12.0; SPSS Sciences, Chicago, IL).
RESULTS
Clinical Data
All clinical parameters showed statistically significant differ-
ences among groups (P  0.001, Kruskal-Wallis test). All com-
parisons among groups are shown in Table 1.
Cell Density Data
There were no significant differences in superficial epithelium
cell density among groups. Basal epithelium cell density was
significantly higher in the C group, compared with other
groups (Table 2).
MG Confocal Data
MGs had significantly higher diameters and lower density in
patients with MGD compared with other groups. SSI and
SSII patients had significantly reduced MG orifice diameters
(Table 3).
MGD patients showed significantly higher secretion reflec-
tivity compared with other groups.
SSI and SSII patients’ secretion reflectivity presented signif-
icant differences compared with MGD and C groups. SSI and
SSII patients showed higher inhomogeneous appearance of
periglandular interstices than did other groups. MGD patients’
interstices’ inhomogeneous appearance was significantly
higher than C but lower than SS patients. SS and MGD patients
showed higher inhomogeneous appearance of the acinar wall
compared with the C group (Table 4).
Secretion reflectivity, inhomogeneous appearance of perig-
landular interstice, and inhomogeneous appearance of the aci-
nar wall showed substantial intra- and interobserver agreement
(K  0.92 and 0.80, respectively), secretion reflectivity (0.86
and 0.78, respectively), inhomogeneous appearance of perig-
landular interstice (0.82 and 0.78, respectively), and inhomo-
geneous appearance of acinar wall.
In SS patients, the grade of inhomogeneous appearance of
periglandular interstices and the acinar wall were significantly
interrelated and correlated with corneal fluorescein staining
(P  0.01, Spearman’s correlation coefficient). Acinar density
and diameter were strongly correlated between themselves
(P  0.001) and with BUT (P  0.05).
DISCUSSION
SS is a chronic autoimmune disorder characterized by dysfunc-
tion and destruction of exocrine glands resulting in an aqueous
tear-deficient dry eye.5 Recent literature suggests that within SS
there exists an organic hybrid form of aqueous-deficient dry
eye (ADDE)—inflammatory infiltration of the lacrimal gland—
and evaporative dry eye (EDE)—MGD.16
LSCM has been recently applied to the armament of modal-
ities used in the examination of MGs, providing a new nonin-
vasive tool with which to study morphologic changes in
MGs.12,14 LSCM is a technology that allows description and
testing of the diagnostic values of acinar density and diameter,
secretion reflectivity, and periglandular inflammation in MGD
patients.
Previous studies12,14 described MGs in vivo confocal ex-
aminations performed through the tarsal conjunctiva of the
inverted superior eyelid. A confocal examination needs a
prolonged contact (a few minutes) between instrument and
examined tissue, which can be uncomfortable for the pa-
tient during inverted superior eyelid tarsal conjunctiva eval-
uation. Moreover the instrument has a space fix orientation,
so it requires the examined tissue to be positioned parallel
to the polymethacrylate sterile cap (Tomo-Cap) face; this is
TABLE 2. Cell Density of Superficial and Basal Epithelium of the
Eyelid Margin
Cell Density (cell/mm2)
Superficial Epithelium Basal Epithelium
SSI 1350  226 3351  217
SSII 1286  277 3987  285
MGD 1278  290 3890  342
C 1473  458 4446  619
P* n.s. 0.001†
n.s., not significant.
* Obtained by Kruskal-Wallis test.
† SSI vs. SSII: P  0.01; SSI vs. C: P  0.001; SSII vs. C: P  0.05;
MGD vs. C: P  0.05; SSI vs. MGD: P  0.05; SSII vs. MGD: n.s.
(Mann-Whitney U test).











SSI 138  69 53  31 27.8  5.9
SSII 97  43 70  42 20.6  5.1
MGD 57  21 106  41 50.0  9.1
C 110  31 53  14 34.7  4.3
P* 0.001† 0.001† 0.001‡
n.s., not significant.
* Obtained by Kruskal-Wallis test.
† SSI vs. SSII: n.s.; SSI vs. C: n.s.; SSII vs. C: n.s.; MGD vs. C: P 
0.001; SSI vs. MGD: P 0.001; SSII vs. MGD: P 0.001 (Mann-Whitney
U test).
‡ SSI vs. SSII: P  0.05; SSI vs. C: P  0.05; SSII vs. C: P  0.001;
MGD vs. C: P 0.001; SSI vs. MGD: P 0.001; SSII vs. MGD: P 0.001
(Mann-Whitney U test).
TABLE 4. Grade of Secretion Reflectivity and Inhomogeneous









SSI 1.7  0.6 2.6  0.6 3.0  1.0
SSII 2.2  0.8 2.6  0.6 2.8  0.8
MGD 3.3  0.7 1.8  0.8 2.5  0.9
C 1.1  0.7 1  0.3 1.4  0.5
P* 0.001† 0.001‡ 0.001§
n.s., not significant.
* Obtained by Kruskal-Wallis test.
† SSI vs. SSII: n.s.; SSI vs. C: P  0.05; SSII vs. C: P  0.001; MGD
vs. C: P  0.001; SSI vs. MGD: P  0.001; SSII vs. MGD: P  0.001
(Mann-Whitney U test).
‡ SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD
vs. C: P  0.001; SSI vs. MGD: P  0.01; SSII vs. MGD: P  0.001
(Mann-Whitney U test).
§ SSI vs. SSII: n.s.; SSI vs. C: P  0.001; SSII vs. C: P  0.001; MGD
vs. C: P  0.001; SSI vs. MGD: n.s.; SSII vs. MGD: n.s. (Mann-Whitney
U test).
IOVS, February 2011, Vol. 52, No. 2 Meibomian Glands in Sjo¨gren’s Syndrome 937
the reason why it is very difficult to evaluate the superior
eyelid margin, whereas the lower one is easily positioned
and inspected. By performing LSCM of the eyelid margin, we
were able to visualize not only the MG acini but also muco-
cutaneous junction epithelia and glandular orifices. We be-
lieve that the chance of studying by in vivo microscopy the
mucocutaneous junction is extremely interesting, not only
because of potential clinical information derivable in the
different pathologies involving this structure, but also be-
cause of its role, recently emphasized in the literature,17,18
as a potential focal point of mucosal epithelial cell differen-
tiation activities.
We performed LSCM of MGs in SS patients, comparing
characteristics with MGD patients and healthy subjects.
The basal mucocutaneous epithelium showed a lower
cell density in SS and MGD patients than in the control
group, suggesting that mechanical and inflammatory damage
cannot be compensated by proliferative changes of the basal
epithelium, as happens, for example, in the cornea.19,20
MGD patients were characterized by extensive MG drop-
out, MG secretion that could not be expressed, tear film
instability, and ocular surface epithelial damage. According
to recent literature,12–14 LSCM in these patients showed
increased diameters of acinar units and orifices and high-
reflective secretion. These alterations may be due to quali-
tative changes of the MG secretion (inspissation, increased
viscosity, and build-up) and to consequent MG obstruction.
Patients with SS showed less acinar dilatation, lower
secretion reflectivity, and decreased orifice diameters, sug-
gesting a minor role for the obstructive pathogenetic mech-
anism.
We interpreted the inhomogeneous appearance of the
periglandular interstices as a confocal sign of eyelid margin
and tarsal inflammation. Previous studies reported quantita-
tive data regarding periglandular inflammatory dendritic cell
density.12,14 In our hands, it was too difficult to identify
individual cells. Furthermore, the dendritic shape was often
unrecognizable. Thus, we chose to perform a semiquantita-
tive analysis (1–4 grading) of the punctiform elements view-
able in the interstices. This inflammatory sign was signifi-
cantly increased in all pathologic groups but was highest in
the SS group.
The inhomogeneous appearance of the acinar wall was
significantly increased in all pathologic groups, with no
differences between SS and MGD patients. This confocal
feature is most likely interpretable as signifying inflamma-
tory processes and changes in MG secretion characteristics.
In conclusion, LSCM offers new opportunities for in vivo
noninvasive histopathological evaluations of the ocular sur-
face. Its application to MGs showed discernible patterns of
MG abnormalities in SS and MGD (Fig. 5), not easily distin-
guishable by usual clinical exams, such as meibography and
MG secretion expression. In SS patients we observed a
prevalence of confocal signs of inflammation, without dila-
tative morphologic changes, while in MGD patients we
found a prevalence of signs of glandular obstruction and
distension.
Further studies regarding confocal features of MGs in
various types of ocular surface diseases could lead to a new
morpho-functional classification of MG alterations and to
additional therapeutic modalities.
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